SCHNETTLER THOMAS P 4
4 · Akoya Biosciences, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
SCHNETTLER THOMAS P
Director
Transactions
- Sale
Common Stock
2022-12-13$13.03/sh−71,050$925,782→ 2,742,721 total(indirect: Held by Piper Sandler Merchant Banking Fund II, L.P.)
Footnotes (1)
- [F1]PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.